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Influenza viruses belong to the family Orthomyxoviridae of enveloped viruses and are
an important cause of respiratory infections worldwide. The influenza virus is able to
infect a wide variety species as diverse as poultry, marine, pigs, horses, and humans.
Upon infection with influenza virus the innate immunity plays a critical role in efficient
and rapid control of viral infections as well as in adaptive immunity initiation. The
humoral immune system produces antibodies against different influenza antigens, of
which the HA-specific antibody is the most important for neutralization of the virus and
thus prevention of illness. Cell mediated immunity including CD4+ helper T cells and
CD8+ cytotoxic T cells are the other arms of adaptive immunity induced upon influenza
virus infection. The complex inherited factors and age related changes are associated
with the host immune responses. Here, we review the different components of immune
responses against influenza virus. Additionally, the correlation of the immune response
to age and inherited factors has been discussed. These determinations lead to a better
understanding of the limitations of immune responses for developing improved vaccines
to control influenza virus infection.
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INTRODUCTION
Influenza virus is a major pathogen that represents an ongoing health threat to several species as
diverse as poultry, swine, and mammals including humans, generally via respiratory morbidity
and mortality (Eyer and Hruska, 2013). Influenza virus is a member of the Orthomyxoviridae
family with an enveloped, negative sense-single stranded RNA (Zhang et al., 2013). They can be
classified into three types: A, B, and C. The influenza A virion genome consists of eight RNA
segments that are varying in sizes, with coding ability of 11 proteins, including Hemagglutinin
(HA), Neuraminidase (NA), Matrix proteins (M1 and M2), Polymerase basic protein (PB1, PB2
and PA), Nucleocapsid protein (NP), PB1-F2 and non-structural proteins (NS1 and NS2; Oh and
Hurt, 2014). HA functions as a mediator for virus entry into the cell by membrane fusion activity
and receptor binding. Meanwhile, NA mediates the progeny virions release by viral receptor
enzymatic cleavage. Integral membrane protein, M2, is a multi-functional, proton-selective, ion
channel which has roles in both virus entry as well as in virus assembly and budding. The matrix
protein (M1) plays an important role in the virion structure and also as a mediator for the
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ribonucleoprotein (RNP) core and the viral lipid membrane. PA,
PB1, PB2 and NP make up the RNP core which plays a critical
role in mediating the packaging and binding of the viral genome.
NS1, NS2, nuclear export protein (NEP) and PB1-F2 are the
three other proteins which are expressed during replication of
the virus and are not merged to the mature virion (Coleman,
2007; Zhang et al., 2013). It has been investigated that NS1 protein
acts as a immunosuppressor by inhibiting type I IFN release and
attenuates the capacity of dendritic cells (DCs) to induce T cell
responses and maturation resulting in inhibition of innate and
adaptive immunity, respectively (Fernandez-Sesma et al., 2006).
Four envelope proteins including HA, NA, NB and BM2 form
the organization of influenza B virion. BM2 protein is similar to
M2 of influenza A virus while the hemagglutinin-esterase-fusion
(HEF) protein is a major surface glycoprotein of the influenza C
viruses. The functionality of this protein corresponds to the HA
and NA of influenza A and B viruses as well as the minor envelope
protein, CM2 (Lamb and Krug, 2001).
Replication Cycle
Influenza virus replication initiates with virus entry into the
host cell via a process of receptor mediated endocytosis. The
virus attaches to sialic acid-containing receptors via the HA
molecule. Two main types of interaction between galactose
(Gal) and sialyloligosaccharides (SAs) are SA-α2, 3-Gal and
SA-α2, 6-Gal. Normally HA proteins of avian influenza virus
(AIV) bind to the SA-α2 and 3-Gal preferentially while a
higher affinity for SA-α2 and 6-Gal linkage is observed for
HA proteins of human influenza virus. The viral entrance into
the cell is through the endocytic pathway. The low pH of
endosome causes a change in the HA protein conformation
leading to exposure of a hydrophobic fusion peptide. After
internalization and fusion of the vesicle with the endosome,
the virus enters into the cytoplasm and the released viral
RNP complexes are transported into the nucleus. In the
nucleus, viral mRNA and complementary RNA (cRNA) will
be synthesized from the vRNPs templates. The synthesized
mRNAs will be exported into cytoplasm for translation of viral
proteins. These newly synthesized proteins are transported to
the nucleus for final assembly of vRNP. cRNAs are then used
as template for synthesis of more negative sense viral RNA
for packaging into progeny virions and amplification of mRNA
synthesis. Finally, viral nucleocapsides are assembled in the
nucleus before being transported back into the cytoplasm and
subsequently form buds at the plasma membrane followed by
release of the new viral particles (Julkunen et al., 2001; Coleman,
2007).
IMMUNE RESPONSES OF INFLUENZA
INFECTION
Innate Immunity
Pathogen Recognition Receptor of Influenza Virus
The innate immunity plays a critical role in efficient and
rapid limitation of viral infections as well as for adaptive
immunity initiation. Different pathogen recognition receptors
(PRRs) in the cells of the innate immune system are utilized
to recognize the influenza A virus. There are three different
PRRs to sense influenza A virus, which includes the retinoic
acid inducible gene I (RIG-I), the Toll-like receptors TLR3,
TLR7 and TLR8 and nucleotide binding oligomerization domain
(NOD)-like receptors (NLRs; Pang and Iwasaki, 2011; Tripathi
et al., 2013). RIG-I is a cytosolic sensor that recognizes the
influenza virus through detection of 5′- triphosphates on single
stranded RNAs. In specialized cells like plasmacytoid dendritic
cells (pDCs), single stranded viral RNA is exposed by viral
capsid degradation in the acidified endosomes for detection
by TLR7. The production of pro-inflammatory cytokines and
type I interferons are induced through the RIG I and TLR7
pathways. IRF7 (interferon regulatory factor 7) and NF-kB
are activated by TLR7 signals which are mediated by MyD88
protein as an adaptor protein. In contrast, RIG I signals can
activate the IRF3 and NF-kB through the IPS I protein which
is located in the mitochondria. Activated IRF3 and IRF7 are
then translocated into the nucleus to induce type I interferon
production. Meanwhile, NF-kB activates the pro-inflammatory
cytokines such as IL-6, TNF-α and IL-1β. Human monocytes and
macrophages express TLR8 and also produce IL-12. However, the
relevance of TLR8 in influenza virus infection is still unidentified.
Recently, several studies have revealed a significant role of
cytoplasmic complexes called inflammasomes in influenza virus
detection. The cytoplasmic inflammasome complex including
the NLR-subset (namely NLRP1, NLRP3 and NLRC4 ) is
able to activate caspase-1 resulting in the pro-IL-1β and IL-
18 production (Loo et al., 2008; Rehwinkel et al., 2010; Pang
and Iwasaki, 2011; Latz et al., 2013; Pothlichet et al., 2013;
Tripathi et al., 2013; Iwasaki and Pillai, 2014; Abderrazak et al.,
2015) (Figure 1). IFN-α/β, IFN-γ and IFN-λ are the results of
activation of all these pathways that led to the induction of the
antiviral response and the activation of neutrophils, recruitment
of macrophages and maturation of DCs (Sanders et al., 2011).
Activation of IFN-α/β as type I IFNs results in antiviral signaling
cascades that involves phosphorylation of tyrosine kinase 2
(Tyk2) and Janus kinase 1 (Jak1), followed by phosphorylation
of signal transducer and activators of transcription (STAT) 1
and STAT2. Finally IFN-stimulated gene factor-3 transcription
factor complex (ISGF3) is formed through the combination
of phosphorylated STAT1 and 2 with IRF9, resulting in the
establishment of an antiviral state in the cell. IFN-γ is the
major type II IFN that establishes an efficient adaptive and
memory cytotoxic T cell response against the influenza virus
infection (Bot et al., 1998; Turner et al., 2007). IFN-λ, a type
III IFN, is responsible for control of influenza A infection in
the lung (Mordstein et al., 2008). One study showed that after
influenza A virus infection pDCs produced higher concentrations
of IFN-λ than monocyte-derived DCs thus implying that
pDCs are the primary cells in IFN-λ production (Ank et al.,
2006).
Macrophages, Natural Killer Cells and Dendritic Cells
The initial phase of the influenza virus infection activates
alveolar macrophages and monocytes which results in a pro-
inflammatory cytokine response involving TNF-α and IL-6.
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FIGURE 1 | The innate and adaptive immunity against influenza virus.
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Alveolar macrophages have beneficial effects in limiting viral
spread either by phagocyte-mediated opsonophagocytosis of
influenza virus particles and phagocytosis of apoptotic infected
cells or by regulating the adaptive immune response (Huber
et al., 2001; Tumpey et al., 2005; Hashimoto et al., 2007; Kim
et al., 2008). Natural killer (NK) cells as cytotoxic lymphocytes
are critical for elimination of influenza virus infection through
two mechanisms. First, they bind to HA proteins through
sialylated NKp44 and NKp46 receptors. Second, NK cells are
able to attach to the Fc portion of antibodies bound to the
influenza virus-infected cells through their CD16 receptor to
mediate lysis of these cells (Guo et al., 2011; van de Sandt
et al., 2012). DCs as professional antigen presenting cells are
characterized as a critical mediator between the innate and
the adaptive immune system. The adaptive immune response
is initiated when DCs present viral antigens to the naïve and
memory T lymphocytes. DCs constantly inspect the lungs for
foreign materials or invading pathogens. During an influenza
virus infection, the antigens are acquired by the DCs through
two different mechanisms. The first mechanism is by direct
infection of DCs, whereby the viral proteins are degraded into
small peptides by proteasomes in the cytosol, transported to the
endoplasmic reticulum (ER) and subsequently loaded to major
histocompatibility complex (MHC) class I molecules. The MHC
class I/peptide complexes are recognized by the virus-specific
CD8+ cytotoxic T cells (CTLs). Phagocytosis of virus particles
or apoptotic epithelial cells is the second mechanism of antigen
acquisition by DCs. Degraded viral proteins are bound to the
MHC class II molecules and these complexes presented on the
cell surface can be recognized by CD4+ T helper cells, which
would then lead to B cells proliferation and maturation into
antibody-producing plasma cells. DCs are also able to present
epitopes to CD8+ T cells via this route of antigen acquisition
which is known as cross-presentation (van de Sandt et al.,
2012).
Adaptive Immunity
Humoral Immunity
The humoral immune system produces antibodies against
different influenza antigens. Understanding host antibody
response is crucial to predict disease severity and for vaccine
development. The HA-specific antibody is the most important
for virus neutralization to prevent illness through binding
to the trimeric globular head of HA, thus inhibiting virus
attachment to the host cells. Additionally, HA-specific antibodies
can bind to the infected Fc receptor-expressing cells to facilitate
phagocytosis of virus particles (de Jong et al., 2000). There
are also antibodies directed against the highly conserved stem
region of the HA, with the ability to neutralize different
subtypes of influenza viruses although the titers are low (Ekiert
et al., 2009, 2011; Sui et al., 2009). Such antibodies would
be useful in stimulating an immune response against all HA
types, however, this has yet to be proven. Antibodies against
NA limit virus spread by inhibiting enzymatic activity and
additionally by facilitating antibody-dependent cell-mediated
cytotoxicity (ADCC). M2-specific antibodies are produced to
a limited extent after natural infection as this protein itself is
present at low concentrations in the infected cells. Besides, NP-
specific antibodies may also contribute during influenza virus
infection. Although the mechanism of protection remains to
be clarified, these antibodies are able to trigger complement
mediated cell lysis of infected cells (Carragher et al., 2008; LaMere
et al., 2011). However, both antigenic drift and shift of the surface
antigens could reduce the effectiveness of antibody binding
to the HA and NA, hence leading to renewed susceptibility
to infection. Nevertheless, heterotypic antibody can convey
substantial immunity depending upon the extent of cross-
reactivity for infecting virus antigens. While serum anti-HA
antibody is the major need for optimal immunity to influenza,
a full complement of immune modalities is desirable to ensure
maximum immunity (Couch, 2002).
The main entrance for many pathogens such as influenza
is the mucosal tissues. Thus, IgA and to some extent, IgM,
may act as the main antibodies in the mucosal tissues by
neutralizing the mucosal pathogens and subsequently to prevent
pathogen entry and virus replication. Neutralizing antibodies,
primarily of the IgA isotype, act especially against the HA and
NA of influenza virus. Induction of primary response occurs
in organized lymphoid tissues while secondary responses may
occur in the periphery. During primary responses, IgM antibody
is initially dominant whereas IgG antibody is dominant during
secondary responses (Cox et al., 2004; Kreijtz et al., 2011; van de
Sandt et al., 2012). It was shown that a higher IgM level could be
associated with a quicker viral clearance and an early good IgM
response is usually necessary for a subsequent good IgG antibody
response. This indicates that there may exist an innate linkage
between early influenza A-specific IgM response and subsequent
IgG antibody production (Qiu et al., 2011). Generally the half-
life of antibodies is short but Ab titers can last a lifetime due to a
subset of the Ab-secreting cells (ASCs) which is long-lived. It has
been shown in the study that transmembrane activator, calcium
modulator, cyclophilin ligand interactor (TACI) cytokines, B
lymphocyte stimulator (BLyS) and proliferation-inducing ligand
(APRIL) have critical roles in producing optimum humoral
immunity and most important in providing protection against
secondary viral infection. Targeting TACI on both innate cells and
B cells for greater antiviral ASC survival can lead to enhanced Ab
titer maintenance and protection (Wolf et al., 2011).
Cellular Immunity
CD4+ and CD8+ T cells are induced upon infection with
influenza virus. Activation of virus specific CD4+ helper T
cells, both Th1 and Th2 type cells, recognize virus-derived
MHC class II-associated peptides on antigen presenting cells,
followed by expression of co-stimulatory molecules (Tamura and
Kurata, 2004). Additionally, T helper 17 (Th17) and regulatory
T cells (Tregs) that control the cellular immune response against
influenza virus infection have been identified. Th17 cells improve
T helper reactions by production of IL-6 which prevents Tregs
function. Tregs control both the CD8+ T cell and the T helper
cell responses after infection. Besides, Tregs do not have any
effect on the B cell response but they are able to suppress
the T helper response (Surls et al., 2010; Campbell and Koch,
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2011). Furthermore, IL-35 secreted by Tregs, acts as suppressor
to inflammatory responses. It has also been shown that IL-
35 is upregulated during secondary pneumococcal pneumonia
following influenza infection (Chen et al., 2016).
Some cytolytic activity of CD4+ T cells is displayed in infected
cells. However, T helper (Th) cells are the most significant
phenotype of these cells. Th cells are divided into two subsets
including Th1 and Th2 cells based on their different cytokine
expression profile. Th1 cells produce IFN-γ and IL-2 and are
involved predominantly in cellular immune response whereas
Th2 cells induce IL-4 and IL-13 production and are shown
to stimulate B cell responses (Kreijtz et al., 2011). The study
on genetically modified mice with the IFN-γ gene disruption
showed enhanced Th2 cytokines induction and influenza-specific
IgG1 antibody production. However, cell mediated immune
responses in these mice were similar to the wild type control.
Remarkably, in vitro re-stimulation of CD4 cell clones which
were isolated from mice with deficient IFN-γ were able to protect
against lethal challenge with influenza virus through a cytolytic
mechanism. Furthermore, CD4 cells showed the ability to lyse
Sendai or LCMV infection in virally infected class-I-deficient
mice indicating the capability of CD4 cells to become killers
themselves for compensation of deficiency in IFN-γ or CD8 cells
(Brown et al., 2004). The ability of CD4+ T cells to prompt
antiviral B cell responses is the most significant contribution of
these cells, which lead to class-switching of antibody, affinity
maturation, and generation of long-lived plasma cell. Distinct
CD4+ T cell subset is considered for this effector activity named
the T follicular helper (Tfh) cell. Since the Tfh cell responses
can have effective implications for immunological memory and
vaccination, it is an area of extreme interest in experimental
influenza infection (Kim et al., 2011).
Upon influenza virus infection, viral epitopes associated with
MHC class I molecules activates the naïve CD8+ T cells in the
draining lymph nodes, which subsequently differentiates into
cytotoxic T lymphocytes (CTLs; Kreijtz et al., 2011; van de
Sandt et al., 2012). Activation of these cells leads to migration
to the infection site where they detect influenza virus-infected
cells and eliminate them via lytic activity and hence inhibit the
virus progeny production. The lytic activity is facilitated by the
perforin and granzymes (e.g., GrA and GrB) secretion (Metkar
et al., 2008). The infected cell membrane is permeabilized by
perforin to assist the entrance of granzymes into the cells
and finally apoptosis induction. Furthermore, GrA shows non-
cytotoxic activities focusing on the prevention of virus replication
via cleavage of viral proteins and host cell proteins that are
involved in protein synthesis (Andrade, 2010; Domselaar and
Bovenschen, 2011). CTLs also have the capability to prompt
apoptosis of infected cells via Fas/FasL interactions. Moreover,
they generate cytokines that increase antigen-presentation by
inducing MHC expression. Post-infection virus-specific CTL
which are developed and preserved under the regulation of
T cell-produced IL-17 and DCs is located in the blood
circulation, the lymphoid organs and also at the site of infection
(GeurtsvanKessel et al., 2009; Rangel-Moreno et al., 2011). These
memory CTL cells are able to activate upon secondary influenza
virus infection. The co-stimulation that they received during their
initial differentiation phase affects their reactivity and affinity
during a secondary infection (van Gisbergen et al., 2011). Human
CTL produced by influenza virus infection are primarily directed
against NP, M1 and PA proteins. These proteins are highly
conserved and therefore the CTL response is cross reactive to
a high degree even between different subtypes of influenza A
viruses (Kreijtz et al., 2011).
INFLUENCE OF AGE AND INHERITED
FACTORS ON IMMUNE RESPONSES TO
INFLUENZA
Toll-like receptors are one the most important PRRs involved in
influenza virus recognition. There are strong evidences showing
correlation between age-associated changes and expression
and function of TLR. In mouse models, lower expression of
TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, and TLR9 was
demonstrated in macrophages of aged mice, which resulted in
the reduction of proinflammatory cytokines such as interleukin
(IL)-6 and tumor necrosis factor (TNF) α upon stimulus with
specified ligands for TLRs (Renshaw et al., 2002; Boehmer et al.,
2005). Additionally, reduced expressions of TLR1, TLR3 TLR8
and TLR7 have been demonstrated in human DCs as well as
lower production levels of IL-6, TNFα, IL-12 and interferon α
(IFNα) upon stimulation with different TLR ligands in elderly
individuals. Similarly, lower levels of TNFα upon TLR4 or
TLR1/2 stimulation by monocytes and macrophages were noted
in elderly individuals (Agius et al., 2009; Panda et al., 2010). pDCs
from aged donors secrete reduced amounts of both IFN-1 and
IFN-III after stimulation with both the TLR7 ligand CpG and
live influenza virus and they also show diminished priming of
CD4/CD8 T-cell immunity and antibody production (Cˇicˇin-Šain
et al., 2010; Panda et al., 2010; Sridharan et al., 2011). CD80
and CD86 as costimulatory molecules expressed on antigen-
presenting cells interact with CD28 and help to activate T cells
(Tsukamoto et al., 2009). Investigations also showed that TLR-
induced CD80 levels were significantly lower in older adults
than young adults. Taken together, both cellular and humoral
immunity to influenza are affected directly by a reduced TLR
response in immune cells from older adults (Van Duin et al.,
2007).
Dendritic cells are characterized as a crucial component
of the innate immune system and also for the initiation of
adaptive immunity. Antigen recognition by PRRs is accompanied
by migration of DCs to regional lymph nodes followed by
differentiation into mature DCs. Furthermore, some cytokines
and chemokines are produced by DCs to activate and to
differentiate T and B cells. Different studies on DCs from
elderly individuals demonstrated a reduction in antigen capture,
migration and finally T-cell activation capacity (Agrawal et al.,
2007; Grolleau-Julius et al., 2008; Agius et al., 2009). Specifically,
decreased upregulation of the costimulatory molecules CD86,
CD80 and human leukocyte antigen (HLA) class I molecules
on DCs from elderly individuals was observed after influenza
stimulation. NK cells are also important in clearance of viral
infection by IFN-γ production and in lysis of infected cells. One
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interesting study showed that the NK cell number is enhanced in
healthy older adults, while in contrast a reduced number of NK
cells was observed in older adults with a weakened health type
leading to an assumption that the activity of NK cells is related to
health status of older adults (Mys´liwska et al., 2004; Zhang et al.,
2007). Moreover, age is associated with alterations in the function
and phenotype of NK cells. In healthy elderly individuals, the
cytotoxic activity of NK cells is decreased at the single cell level
but as numbers of NK cells increased, total NK cell mediated
cytotoxicity is preserved (DelaRosa et al., 2006). In contrast,
lower NK cell-mediated cytotoxicity has been investigated in
frail individuals and elderly with chronic diseases (Bruunsgaard
et al., 2001). No CD16 expression and their ability to activate
antibody dependent NK cell cytotoxicity are influenced by age
(DelaRosa et al., 2006). Regarding the phenotypes, aging causes to
decrease the expression of some cytotoxicity activating receptors
such as DNAM-1, NKp30 and NKp46 (Bruunsgaard et al.,
2001). The effect of age on the inhibitory receptors expression
of NK cells such as KIR receptor or CD94/NKG2A is very
controversial. Some studies did not show significant differences
in the expression of CD94/NKG2A and KIR in elderly compared
with young individuals (Garff-Tavernier et al., 2010) while the
others found an enhancement in the KIR expression and a
reduction expression of CD94/NKG2A receptor in elderly (Lutz
et al., 2005).
Several data showed that aging significantly affects humoral
immune responses through noticeable effects on generation and
function of B cells. It has been demonstrated that production
of high affinity antibodies is diminished in elderly population
because of some deficiencies in somatic hypermutation and
isotype switching (Frasca et al., 2005). Moreover, decreased
diversity of antibody reactions was observed with aging due
to an ongoing reduction in naïve B cells and hence an
observed decrease in effector B cells (Allman and Miller, 2005).
Additionally, an impaired ability of bone marrow cells to support
survival of antibody-producing plasma B cells was observed in
older mice (Han et al., 2003).
Within the T-cell compartment age-related changes are also
evident. As involution of the thymus starts early in life, the
output of naïve T cells reduces considerably with age, resulting
in decreased numbers of naïve T cells in the periphery in elderly
individuals. Lifespan and homeostatic turnover of naïve T cells
will increase in order to compensate the decreased peripheral
T cells which significantly cause a reduction in the diversity of
the T-cell receptor (TCR) repertoire. Furthermore, a decreased
TCR repertoire has been related to an inadequate vaccination
response and reduced immunity against influenza virus (Cˇicˇin-
Šain et al., 2007; Kilpatrick et al., 2008; Ahmed et al., 2009;
Tsukamoto et al., 2009). Moreover, a deficiency in the production
of granzyme B in CD8+ T cells as well as IFN-γ has been
demonstrated in vaccinated older adults (Lee et al., 2011; Zhou
and McElhaney, 2011). Another molecule, CD28, is a critical
component that differentiates naïve T cells after antigen exposure.
It was shown that the expression of this molecule on the CD8+
T cells decreases with age leading to a poor immune response
to influenza vaccine (Goronzy et al., 2001). Aging also causes
the accumulation of highly differentiated effector-memory CD8
T cells with characteristics of replicative senescence. In this case
the capacity to proliferate decreases, telomeres are shortened,
telomerase activity is lost and CD28 expression is reduced (Pera
et al., 2015). The effect of aging on the immune responses has
been summarized in Figure 2.
It is generally believed that multiple defects in the immune
responses including diminished anti-hemagglutinin (HA)
antibody titers as well as diminished specificity of these
antibodies causes a reduction in the efficacy of influenza vaccine
in the elderly (Sasaki et al., 2011). These reduced responses
are linked to a reduced heterogeneity in the B cell pool and
reduced production of B cell precursors in the bone marrow, as
mentioned earlier. As infectious disease in the elderly imposes
high economic and social costs, most developed countries
provide a comprehensive program to vaccinate the individuals
over the age of 65 (Trzonkowski et al., 2009). Advances in our
understanding about alterations in immune system in the elderly
as well as exploiting those alterations to induce more robust and
long-lasting reactions to vaccine contents may help to improve
the current vaccination for the elderly. Moreover, various
strategies are used to induce greater antigen-specific antibody
responses and to maximize cross-protective immunogenicity
including adjuvanted vaccines, alternate routes of immunization,
universal vaccine strategies and high-dose vaccines (Haq and
McElhaney, 2014).
Considering the different behavior of immune responses in
elderly individuals, it is worth suggesting more investigations
into the important protective factors such as specific and
non-specific antibodies against influenza virus in the elderly.
Additionally, correlation between age dependent comorbidities
such as chronic respiratory conditions, metabolic disorders,
cardiovascular, hepatic, renal and hematological and influenza
virus infection, and its effect on the immune response needs to be
investigated, as these underlying conditions may have an impact
on the quality of the immune response to be generated. Besides,
the need to study the potential of daily routines such as nutrition
and exercising for increasing the immune responses in elderly
people is also required.
The function of environmental agents in immune aging
remains incompletely understood. For example, latent
cytomegalovirus (CMV) infection has been associated with
an immune risk profile in the elderly humans. Mouse CMV
infection showed selected T-cell subset changes associated with
immune aging, specifically the enhancement of relative and
absolute counts of CD8 T-cells in the blood, with a decreased
representation of the naïve and the increased representation of
the effector memory blood CD8 T-cells. Additionally, weaker
CD8 responses to superinfection with influenza were observed
in mouse CMV infection, even 16 months following CMV
infection (Cicin-Sain et al., 2012). It also has been documented
that human CMV has negative effect on the in vivo and in vitro
B cell responses to the seasonal influenza vaccine (Sansoni
et al., 2014). Conversely, other studies showed that acute and
early latent MCMV infection resulted in improved control of
influenza virus infection. The lungs of influenza-infected animals
have been filtered by MCMV-specific CD8+ T cells several
days prior to the influenza-specific CD8+ T cell response. This
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FIGURE 2 | Effect of aging on the immune responses.
ability is due to producing significant amounts of the cytokines
IFN-γ and TNF-α (Barton et al., 2007; Furman et al., 2015).
Although multiple studies suggest that persistent CMV infection
is associated with accelerated aging of the immune system and
with several age-related diseases, however, how CMV infection
is implicated in immunosenescence and in age-related diseases
remains controversial (Sansoni et al., 2014).
It is also important to mention that besides age-related
changes, the immune system shows significant sex-specific
differences. It is well established that the aging process affects
sexual dimorphism regarding immunocompetence and disease
susceptibility. This influences on the etiopathology of infectious
diseases like influenza virus as main causes of morbidity
and mortality in older people (Giefing-Kröll et al., 2015).
Particularly, men exhibited to be more concerned by seasonal
influenza, whereas premenopausal women surrender more
often to pandemic strains. Moreover, it has been investigated
that, enhanced stimulation of pro-inflammatory cytokines and
chemokines are associated with higher morbidity and mortality
in infected-influenza virus women (Klein et al., 2012; Quandelacy
et al., 2014). However, stronger humoral responses were observed
in vaccination against influenza in women. These results suggest
that conclusively during aging, interventions, which distinctively
consider the changing level of individual hormones, may provide
potent options in maintaining optimal immune functions
(Giefing-Kröll et al., 2015).
Based on some evidences showing an inherited susceptibility
to the influenza virus infection and death, genetic associations
with the immune response and influenza infection is also
intensely suggested (Albright et al., 2008). Heat shock protein
gene, heme oxygenase-1 (HO-1) has been identified as an effective
gene in immune responses to influenza virus infection. Several
studies showed the relationship between the increased levels of
HO-1 gene and immune responses against influenza infection.
Furthermore, decreased antibody production in response to
influenza vaccination was observed in aged HO-1-deficient mice
(Cummins et al., 2012). Critically, the strong association between
impaired influenza vaccine responses and polymorphisms in
the HO-1 gene has been demonstrated. Hence it is essential to
investigate the HO-1 and other gene polymorphisms to improve
the understanding of genetic determinants for influenza control
and vaccine efficiency.
There are several studies showing the important role of
host genetic polymorphisms on immunity against influenza
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TABLE 1 | Host genetic polymorphisms associations with the immune response and influenza infection.
Host genetic polymorphisms Function of the molecules
Heme oxygenase-1 (HO-1) Responsible for the anti-inflammatory response to severe influenza infection
HLA class I Responsible for the presentation of antigenic epitopes to CD8+
HLA class II Responsible for the presentation of antigenic epitopes to CD4+ T cells
Single nucleotide polymorphisms in TLRs Central to antiviral innate immunity
RIG-1 Recognition of double-stranded RNA and contribute to the antiviral state of an infected cell and
involved in the influenza virus-specific production of IFN-β.
Single nucleotide polymorphisms in cytokine ( IFN-g, IL12A,
IL12B, IL18 and IL6)
Central to antiviral innate immunity
Single nucleotide polymorphisms in cytokine receptors
(IFNAR2, IL1R, TNFRSF1A, IL4R, IL2RG, IL12RB and
IL10RB)
Central to antiviral innate immunity
Immunoglobulin heavy chain variable (IGHV) Responsible for the diversity of the humoral immune system
MX1, IFITM3, IRF7, STAT2, OAS2, and IFI44L Components of the interferon pathway and innate immunity
infection. It has been revealed that HLA and other immunity-
related gene polymorphisms have critical roles in induction
of humoral immunity against influenza virus. HLA class I
and class II molecules are responsible for the presentation of
antigenic epitopes to CD8+ and CD4+ T cells, respectively,
which consequently induces T-cell populations with distinct
functions. The correlation between various HLA class I and
class II alleles and the immune response to influenza vaccination
have been reported (Marchant et al., 2006). Some studies on
TLR4 as a critical component of innate immunity in the
recognition of lipopolysaccharide showed that the TLR4 gene
polymorphisms is important in the immune responses against
respiratory syncytial virus and as a consequence, were susceptible
to severe RSV disease (Marchant et al., 2006). Additionally, IFN-
β generation to control the influenza infection is influenced by
interaction with the RIG-1 gene. Influenza virus NS1 protein
is able to prevent the RIG-1 pathway by interaction with
RIG-1, resulting in inhibition of IFN-β production (Marchant
et al., 2006). Significant correlations has been demonstrated
between influenza H1-specific HAI antibody levels and single
nucleotide polymorphisms in cytokine genes (IFN-g, IL12A,
IL12B, IL18 and IL6), and cytokine receptor genes (IFNAR2,
IL1R, TNFRSF1A, IL4R, IL2RG, IL12RB and IL10RB; Gelder
et al., 2002; Poland et al., 2008; Cummins et al., 2012). The
polymorphism of the immunoglobulin heavy chain variable
region (IGHV) exhibits the diversity of the humoral immune
system. The role of IGHV1-69 germline gene to generate
the neutralizing antibodies against stem region of HA of
influenza virus and generally to regulate B cell function and
antibody repertoire expression has been investigated (Avnir
et al., 2016). Also important genes involved in maturation and
function of DCs, antigen presentation, and membrane trafficking
and apoptosis of infected cells mediated by TCLs have been
investigated (Franco et al., 2013). In addition, one study showed
the upregulation of components of the interferon pathway and
innate immunity including MX1, IFITM3, IRF7, STAT2, OAS2,
and IFI44L in the acute phase of infection. Investigations also
showed that differential expression of genes in the recovery
phase of infection is disguisable from acute phase suggesting
the strong association between a gene expression signature and
influenza virus infection (Zhai et al., 2015). Development of new
vaccines against influenza virus needs a strong understanding
of genetic effects on the immune responses. Identification of
interactions between different pathways of critical gene and
immune responses will result in a better understanding of the
host response to influenza virus and influenza vaccine antigens.
The host genetic polymorphisms associations with the immune
response and influenza infection have been summarized in
Table 1.
It is worth to mention that influenza epidemics extremely
affect elderly people with the highest rates of morbidity and
mortality. The mortality rate increases dramatically with age, with
the risk in people aged 80 years and above at an approximately
11-fold higher than the people aged 65–69 years. Moreover,
in recent decades, about 90% of all influenza-related deaths
occurred among the senior citizens, 75% aged 70 years while
55% aged over 80 years. Additionally, poor immune responses
account for reduced efficacy of vaccines in people aged over
65 years. However, for occasional severe seasons, poor immune
responses with surge in deaths can often be seen in children and
young adults (Simonsen et al., 2009). Studies by the Centre of
Disease Control (CDC) showed that flu vaccination decreased
the risk of a more serious flu effect by evolution of the immune
responses. For example, a recent study showed that flu vaccine
decreased children’s risk by 74% during flu seasons from 2010–
2012. Another study also showed that flu vaccination caused a
reduction of 71% in flu-related hospitalizations among adults and
77% among adults 50 years of age and older during the 2011–
2012 flu seasons (CDC, 2013). Lower rates were also observed
in some vaccinated people with heart disease and diabetes (79%)
and chronic lung disease (52%). The flu vaccine was also effective
in preventing hospitalization of infants and pregnant women by
92% (CDC, 2013).
GENERAL CONCLUSION
Despite many efforts and investigations in the field of immune
responses against influenza viruses, there are still major gaps
toward understanding the different factors of immune system and
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their viral targets. Research focused on the immune mechanisms
of protection against influenza viruses and specifically the
induction of CTL responses to conserved epitopes can be useful
for creating novel vaccines and other involvement approaches.
Several factors like age, sex, and inherited factors in immunity
against influenza infection are also complex phenomena that may
cause several changes in different components of the immune
system. Specifically, critical characteristics of immunosenescence
include: decreased number and function of DCs; alteration
in number of NK cell; decreased number of naive T and
B cells; reduction in the diversity of the TCR; reduction in
production of high affinity antibodies and diversity of antibody
reactions. A decline in immune responses including innate
and adaptive immune systems in the elderly leads to more
susceptibility to infection and consequently, responsiveness of
vaccine is compromised, especially in frail elderly individuals.
The development and identification of immunosenescence
markers in patients with impaired responses to vaccination
may help to decrease morbidity and mortality of infections
in the aged people. Generally, to ensure protection against
influenza, development of improved treatments specifically
vaccines addressing the affected parts of the immune system by
several factors is needed leading to develop our ability to prevent
influenza virus infections in the future.
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